1. Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells
   Surya Kant Tripathi et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
2. The promising potential of piperlongumine as an emerging therapeutics for cancer
   Dey Parama et al, 2021, Exploration of Targeted Anti-tumor Therapy CrossRef
3. Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells
   Valdenizia R. Silva et al, 2021, Cancer Communications CrossRef
4. The Synergistic Effect of Piperlongumine and Sanguinarine on the Non-Small Lung Cancer
   Marta Hałas-Wiśniewska et al, 2020, Molecules CrossRef